Chimeric Antigen Receptor T Cell Therapy For Solid Tumors
Chimeric antigen receptor T (CAR T) cell therapy has revolutionized the management of lymphoid malignancies. However, it is still in its early phase and is facing many obstacles in solid tumors. Therapeutic challenges in solid tumor lead to tumor target diversification and drive new innovations for...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wolters Kluwer Medknow Publications
2022-07-01
|
| Saila: | Hematology/Oncology and Stem Cell Therapy |
| Gaiak: | |
| Sarrera elektronikoa: | https://journals.lww.com/10.56875/2589-0646.1028 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|